Shingles Vaccine Linked to 24% Lower Dementia Risk in Elderly Study

A new study suggests that the vaccine for shingles, commonly known as "the serpent skin," may offer an unexpected benefit beyond preventing the painful rash: a reduced risk of dementia. The research, which analyzed the health records of over half a million elderly Americans living in nursing homes, found a significant correlation between receiving the Shingrix vaccine and a lower likelihood of developing dementia.

Conducted by a team at Brown University's School of Public Health and published in the Annals of Internal Medicine, the study examined data from 509,926 Medicare beneficiaries aged 66 and older who resided in nursing facilities. After tracking these individuals for four years, the researchers discovered that 18.8% of those who received at least one dose of the Shingrix vaccine were diagnosed with dementia, compared to 24.6% of those who did not receive the vaccine. This translates to an approximate 24% reduction in dementia diagnosis risk among the vaccinated group.

“

The average of 17 cases of dementia, one may have been related to vaccination and did not occur.

Lead researcher Kaley Hayes noted that the findings suggest that for every 17 cases of dementia, one might have been prevented by vaccination. While previous studies had indicated a link between an older version of the shingles vaccine and reduced dementia risk, this research specifically focused on the currently used Shingrix vaccine and a high-risk population in nursing homes. The study's design aimed to mitigate biases inherent in observational research by simulating a randomized clinical trial using large medical datasets.

However, the researchers are cautious about drawing definitive conclusions. They stress that the study, being observational, cannot establish a direct causal relationship between the vaccine and lower dementia risk. Although the study adjusted for factors like age and general health, other unmeasured variables could still be influencing the results. Further clinical trials are deemed necessary to confirm these findings and explore the potential mechanisms behind this observed association, which may involve the vaccine's impact on overall brain health.

“

This study shows that the vaccine originally used to prevent shingles may have additional benefits for brain health, in addition to reducing the risk of infection, but related mechanisms still need more research to be confirmed.